BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22140072)

  • 1. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system.
    Bhandary YP; Shetty SK; Marudamuthu AS; Gyetko MR; Idell S; Gharaee-Kermani M; Shetty RS; Starcher BC; Shetty S
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L463-73. PubMed ID: 22140072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.
    Bhandary YP; Shetty SK; Marudamuthu AS; Ji HL; Neuenschwander PF; Boggaram V; Morris GF; Fu J; Idell S; Shetty S
    Am J Pathol; 2013 Jul; 183(1):131-43. PubMed ID: 23665346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury.
    Shetty SK; Bhandary YP; Marudamuthu AS; Abernathy D; Velusamy T; Starcher B; Shetty S
    Am J Respir Cell Mol Biol; 2012 Oct; 47(4):474-83. PubMed ID: 22592924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.
    Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S
    Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of p53-mediated changes in the uPA-fibrinolytic system and in lung injury by loss of surfactant protein C expression in alveolar epithelial cells.
    Puthusseri B; Marudamuthu A; Tiwari N; Fu J; Idell S; Shetty S
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L783-L796. PubMed ID: 28385810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.
    Shetty S; Padijnayayveetil J; Tucker T; Stankowska D; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L967-75. PubMed ID: 18836029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis.
    Shetty SK; Tiwari N; Marudamuthu AS; Puthusseri B; Bhandary YP; Fu J; Levin J; Idell S; Shetty S
    Am J Pathol; 2017 May; 187(5):1016-1034. PubMed ID: 28273432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells.
    Gouda MM; Prabhu A; Bhandary YP
    J Cell Biochem; 2018 Feb; 119(2):2222-2230. PubMed ID: 28902433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Lung Injury: IL-17A-Mediated Inflammatory Pathway and Its Regulation by Curcumin.
    Gouda MM; Bhandary YP
    Inflammation; 2019 Aug; 42(4):1160-1169. PubMed ID: 31011925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury.
    Bhandary YP; Shetty SK; Marudamuthu AS; Midde KK; Ji HL; Shams H; Subramaniam R; Fu J; Idell S; Shetty S
    PLoS One; 2015; 10(5):e0123187. PubMed ID: 25932922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p53-fibrinolytic system cross-talk in the regulation of quartz-induced lung injury.
    Bhandary YP; Shetty SK; Marudamuthu AS; Fu J; Pinson BM; Levin J; Shetty S
    Toxicol Appl Pharmacol; 2015 Mar; 283(2):92-8. PubMed ID: 25596429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease.
    Jiang C; Liu G; Luckhardt T; Antony V; Zhou Y; Carter AB; Thannickal VJ; Liu RM
    Aging Cell; 2017 Oct; 16(5):1114-1124. PubMed ID: 28722352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin down-regulates IL-17A mediated p53-fibrinolytic system in bleomycin induced acute lung injury in vivo.
    Gouda MM; Bhandary YP
    J Cell Biochem; 2018 Sep; 119(9):7285-7299. PubMed ID: 29775223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes.
    Sisson TH; Hattori N; Xu Y; Simon RH
    Hum Gene Ther; 1999 Sep; 10(14):2315-23. PubMed ID: 10515451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.
    Makarova AM; Lebedeva TV; Nassar T; Higazi AA; Xue J; Carinato ME; Bdeir K; Cines DB; Stepanova V
    J Biol Chem; 2011 Jul; 286(26):23044-53. PubMed ID: 21540184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats.
    Zhang YP; Li WB; Wang WL; Liu J; Song SX; Bai LL; Hu YY; Yuan YD; Zhang M
    Acta Pharmacol Sin; 2012 Jul; 33(7):897-908. PubMed ID: 22659625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin intervention during progressive fibrosis controls inflammatory cytokines and the fibrinolytic system in pulmonary fibrosis.
    Fathimath Muneesa M; Barki RR; Shaikh SB; Bhandary YP
    Toxicol Appl Pharmacol; 2022 Aug; 449():116116. PubMed ID: 35716765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.